Showing 881-890 of 1066 results for "".
- Four Genetic Markers Connected to Progressive Multifocal Leukoencephalopathyhttps://practicalneurology.com/news/four-genetic-markers-connected-to-progressive-multifocal-leukoencephalopathy/2470084/Scientists whose research has been published in Frontiers in Neurology have identified 4 specific genes associated with progressive multifocal leukoencephalopathy (PML). The 4 genes are C8B, LY9 (
- Subjective Cognitive Decline Linked to Higher Dementia Risk for Black and Latinx Peoplehttps://practicalneurology.com/news/subjective-cognitive-decline-linked-to-higher-dementia-risk-for-black-and-latinx-people/2470072/According to a study published in Neurology, some people report a decline in their memory before the decline is large enough to appear on standardized tests. This subjective cognitive decline is associated with an increased risk of developing dementia in Black and Latinx people. <
- Air Pollution Correlated With High Risk of in-Hospital Death From Strokehttps://practicalneurology.com/news/air-pollution-correlated-with-high-risk-of-in-hospital-death-from-stroke/2469919/A new study published in Neurology states high air pollution has an association with increased in-hospital death from stroke. Study researchers evaluated 3.1 million records of people hospitalized with an
- Antisense Oligonucleotide for Potential Treatment of C9orf72-Related Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Decreases Dipeptide Repeat Proteinshttps://practicalneurology.com/news/antisense-oligonucleotide-for-potential-treatment-of-c9orf72-related-amyotrophic-lateral-sclerosis-and-frontotemporal-dementia-decreases-dipeptide-repeat-proteins/2469871/In the ongoing phase 1b/2a FOCUS-C9 clinical trial (NCT04931862) of an antisense oligonucleotide (ASO) (WVE-004; Wave Life Sciences, Cambridge, MA) for potential treatment of C9orf72-associated amyotrophic lateral sclerosis and frontot
- Phase 3 Study of Tolperisone for Muscle Spasms Completes Enrollmenthttps://practicalneurology.com/news/phase-3-study-of-tolperisone-for-muscle-spasms-completes-enrollment/2469759/Enrollment of 1,000 participants is complete for the phase 3 RESUME-1 study (NCT04671082) of tolperisone (Mydocalm; Neurana Pharmaceuticals, San Diego, CA) for muscle spasms associated with acute,
- Ganaxolone Reduces Seizure Frequency in Tuberous Sclerosis Complexhttps://practicalneurology.com/news/ganaxolone-reduces-seizure-frequency-in-tuberous-sclerosis-complex/2469673/In an open-label phase 2 trial (NCT04285346), ganaxolone (Marinus Pharmaceuticals, Radnor, PA) treatment of 23 participants with seizures associated with tuberous sclerosis complex (TSC) reduced s
- FDA Approves Implanted Spinal Cord Stimulator for Chronic Painful Diabetic Neuropathyhttps://practicalneurology.com/news/fda-approves-implanted-spinal-cord-stimulator-for-chronic-painful-diabetic-neuropathy/2469638/The Food and Drug Administration (FDA) granted premarket approval to an implanted spinal cord stimulator (Senza System; Nevro, Redwood City, CA) for treatment of chronic pain associated with painful diabetic neuropathy (PDN). As published in
- Pursuit of Alzheimer Disease Treatments Relying Heavily on Publicly and Academically Funded Research as Pharma Steps Backhttps://practicalneurology.com/news/pursuit-of-alzheimer-disease-treatments-relying-heavily-on-publicly-and-academically-funded-research-as-pharma-steps-back/2469598/The journal Alzheimer's & Dementia: Translational Research & Clinical Interventions and Studies, published by the Alzheimer's Association, has published 2 studies showing a shift in how rese
- Risk of In-Hospital Stroke Higher Among Those With COVID-19https://practicalneurology.com/news/risk-of-in-hospital-stroke-higher-among-those-with-covid-19/2469530/A study presented at the American Stroke Association’s virtual International Stroke Conference 2021 showed individuals hospitalized with COVID-19 had a higher risk of stroke compared to those who were h
- Plasmapheresis With Albumin Delays Cognitive and Functional Declines in Clinical Trial for Alzheimer Diseasehttps://practicalneurology.com/news/plasmapheresis-with-albumin-delays-cognitive-and-functional-declines-in-clinical-trial-for-alzheimer-disease/2469334/The Journal of the Alzheimer's and Dementia Association, the peer-reviewed scientific journal, today has published Results from the Alzheimer's disease Management by Albumin Replacement (AMBAR) study (